ACSS2 expression is up-regulated under metabolically stressed conditions (low oxygen and low nutrient/lipid availability) and ACSS2 silencing has been shown to reduce the growth of tumor xenografts [92]. This evidence concerns the gene ACSS2 and neoplasm.